AAAAAA

   
Results: 1-19 |
Results: 19
PHASE-I STUDY OF TOPOTECAN (T) AND EPIRUBICIN (E) IN ADVANCED EPITHELIAL OVARIAN-CANCER (OVCA) RESISTANT OR REFRACTORY TO PACLITAXEL AND CARBOPLATIN (PC) FIRST LINE CHEMOTHERAPY
Authors: BOLIS G SCARFONE G VILLA A MANGILI G PIRIETTI E POLATTI A REINA S SPATTI GB
Citation: G. Bolis et al., PHASE-I STUDY OF TOPOTECAN (T) AND EPIRUBICIN (E) IN ADVANCED EPITHELIAL OVARIAN-CANCER (OVCA) RESISTANT OR REFRACTORY TO PACLITAXEL AND CARBOPLATIN (PC) FIRST LINE CHEMOTHERAPY, Annals of oncology, 9, 1998, pp. 331-331
DOUBLE-BLIND, DOSE-FINDING STUDY OF 4 INTRAVENOUS DOSES OF DEXAMETHASONE IN THE PREVENTION OF CISPLATIN-INDUCED ACUTE EMESIS
Authors: ROILA F BALLATORI E DEANGELIS V TONATO M DELFAVERO A CICCARESE G BASURTO C CICCARESE G PALLADINO MA PORROZZI S PICCIAFUOCO M CONTU A OLMEO N PAZZOLA A PILO L TATEO S CHIAPPARINI I MORANA S LUCCHINO S RICCI S ANTONUZZO A ALLEGRINI G GALLI L CONTE PF MASSIDDA B IONTA MT SCANU A MURRU R PICECE V CIRILLO M MAGAROTTO R NUZZO A LAUDADIO L SABLONE MG LOCATELLI MC DANTONA A LUPORINI G SCAGLIOTTI G SELVAGGI G MATTEI A FAVALLI G GAMBINO A FAVA S GRIMI E SCARFONE G BOLIS MC ALESSANDRONI P CATALANO G BONI C MORETTI G CORTESI E MARTELLI O ANTIMI M BELLINI V BUZZI E BRUGIA M GRECCHI M CLERICO M MONTINARI F DONATI D SANSONI E
Citation: F. Roila et al., DOUBLE-BLIND, DOSE-FINDING STUDY OF 4 INTRAVENOUS DOSES OF DEXAMETHASONE IN THE PREVENTION OF CISPLATIN-INDUCED ACUTE EMESIS, Journal of clinical oncology, 16(9), 1998, pp. 2937-2942
THE CLINICAL PREDICTIVITY OF BIOMARKERS OF STAGE III-IV EPITHELIAL OVARIAN-CANCER IN A PROSPECTIVE RANDOMIZED TREATMENT PROTOCOL
Authors: SILVESTRINI R DAIDONE MG VENERONI S BENINI E SCARFONE G ZANABONI F VILLA A PRESTI M DANESE S BOLIS G
Citation: R. Silvestrini et al., THE CLINICAL PREDICTIVITY OF BIOMARKERS OF STAGE III-IV EPITHELIAL OVARIAN-CANCER IN A PROSPECTIVE RANDOMIZED TREATMENT PROTOCOL, Cancer, 82(1), 1998, pp. 159-167
A PHASE I-II TRIAL OF FIXED-DOSE CARBOPLATIN AND ESCALATING PACLITAXEL IN ADVANCED OVARIAN-CANCER
Authors: BOLIS G SCARFONE G ZANABONI F VILLA A PRESTI M MELPIGNANO M FERRARIS C TATEO S GUARNERIO P GENTILE A PARAZZINI F
Citation: G. Bolis et al., A PHASE I-II TRIAL OF FIXED-DOSE CARBOPLATIN AND ESCALATING PACLITAXEL IN ADVANCED OVARIAN-CANCER, European journal of cancer, 33(4), 1997, pp. 592-595
WEEKLY CISPLATIN GIVEN FOR 2 MONTHS VERSUS CISPLATIN PLUS CYCLOPHOSPHAMIDE GIVEN FOR 5 MONTHS AFTER CYTOREDUCTIVE SURGERY FOR ADVANCED OVARIAN-CANCER
Authors: BOLIS G FAVALLI G DANESE S ZANABONI F MANGILI G SCARABELLI C TATEO S VALSECCHI MG SCARFONE G RICHIARDI G FRIGERIO I MELPIGNANO M VILLA A PARAZZINI F
Citation: G. Bolis et al., WEEKLY CISPLATIN GIVEN FOR 2 MONTHS VERSUS CISPLATIN PLUS CYCLOPHOSPHAMIDE GIVEN FOR 5 MONTHS AFTER CYTOREDUCTIVE SURGERY FOR ADVANCED OVARIAN-CANCER, Journal of clinical oncology, 15(5), 1997, pp. 1938-1944
TOPOTECAN, A NEW DRUG FOR THE TREATMENT O F EPITHELIAL OVARIAN-CANCER
Authors: SCARFONE G VILLA A MORANA S
Citation: G. Scarfone et al., TOPOTECAN, A NEW DRUG FOR THE TREATMENT O F EPITHELIAL OVARIAN-CANCER, Tumori, 83(6), 1997, pp. 11-14
A PHASE-I TRIAL WITH FIXED-DOSE CARBOPLATIN AND ESCALATING DOSES OF PACLITAXEL IN ADVANCED OVARIAN-CANCER
Authors: BOLIS G SCARFONE G VILLA A ACERBONI S SILIPRANDI V GUARNERIO P
Citation: G. Bolis et al., A PHASE-I TRIAL WITH FIXED-DOSE CARBOPLATIN AND ESCALATING DOSES OF PACLITAXEL IN ADVANCED OVARIAN-CANCER, Seminars in oncology, 24(1), 1997, pp. 23-25
TOPOTECAN, AN ACTIVE-DRUG IN THE 2ND-LINE TREATMENT OF EPITHELIAL OVARIAN-CANCER - RESULTS OF A LARGE EUROPEAN PHASE-II STUDY
Authors: CREEMERS GJ BOLIS G GORE M SCARFONE G LACAVE AJ GUASTALLA JP DESPAX R FAVALLI G KREINBERG R VANBELLE S HUDSON I VERWEIJ J HUININK WWT
Citation: Gj. Creemers et al., TOPOTECAN, AN ACTIVE-DRUG IN THE 2ND-LINE TREATMENT OF EPITHELIAL OVARIAN-CANCER - RESULTS OF A LARGE EUROPEAN PHASE-II STUDY, Journal of clinical oncology, 14(12), 1996, pp. 3056-3061
DETERMINANTS OF RESPONSE TO A CISPLATIN-BASED REGIMEN AS NEOADJUVANT CHEMOTHERAPY IN STAGE IB-IIB INVASIVE CERVICAL-CANCER
Authors: BOLIS G VANZAINTENPRZYBYSZ I SCARFONE G ZANABONI F SCARABELLI C TATEO S CALABRESE M PARAZZINI F
Citation: G. Bolis et al., DETERMINANTS OF RESPONSE TO A CISPLATIN-BASED REGIMEN AS NEOADJUVANT CHEMOTHERAPY IN STAGE IB-IIB INVASIVE CERVICAL-CANCER, Gynecologic oncology, 63(1), 1996, pp. 62-65
SURVIVAL OF WOMEN WITH ADVANCED OVARIAN-CANCER AND COMPLETE PATHOLOGICAL RESPONSE AT 2ND-LOOK LAPAROTOMY
Authors: BOLIS G VILLA A GUARNERIO P FERRARIS C GAVONI N GIARDINA G MELPIGNANO M SCARFONE G ZANABONI F PARAZZINI F
Citation: G. Bolis et al., SURVIVAL OF WOMEN WITH ADVANCED OVARIAN-CANCER AND COMPLETE PATHOLOGICAL RESPONSE AT 2ND-LOOK LAPAROTOMY, Cancer, 77(1), 1996, pp. 128-131
REGRESSION OF ADVANCED OVARIAN-CARCINOMA BY INTRAPERITONEAL TREATMENTWITH AUTOLOGOUS T-LYMPHOCYTES RETARGETED BY A BISPECIFIC MONOCLONAL-ANTIBODY
Authors: CANEVARI S STOTER G ARIENTI F BOLIS G COLNAGHI MI DIRE EM EGGERMONT AMM GOEY SH GRATAMA JW LAMERS CHJ NOOY MA PARMIANI G RASPAGLIESI F RAVAGNANI F SCARFONE G TRIMBOS JB WARNAAR SO BOLHUIS RLH
Citation: S. Canevari et al., REGRESSION OF ADVANCED OVARIAN-CARCINOMA BY INTRAPERITONEAL TREATMENTWITH AUTOLOGOUS T-LYMPHOCYTES RETARGETED BY A BISPECIFIC MONOCLONAL-ANTIBODY, Journal of the National Cancer Institute, 87(19), 1995, pp. 1463-1469
SINGLE-DOSE INTRAPERITONEAL RADIOIMMUNOTHERAPY WITH THE MURINE MONOCLONAL-ANTIBODY I-131 MOV18 - CLINICAL-RESULTS IN PATIENTS WITH MINIMAL RESIDUAL DISEASE OF OVARIAN-CANCER
Authors: CRIPPA F BOLIS G SEREGNI E GAVONI N SCARFONE G FERRARIS C BURAGGI GL BOMBARDIERI E
Citation: F. Crippa et al., SINGLE-DOSE INTRAPERITONEAL RADIOIMMUNOTHERAPY WITH THE MURINE MONOCLONAL-ANTIBODY I-131 MOV18 - CLINICAL-RESULTS IN PATIENTS WITH MINIMAL RESIDUAL DISEASE OF OVARIAN-CANCER, European journal of cancer, 31A(5), 1995, pp. 686-690
ONDANSETRON VERSUS GRANISETRON, BOTH COMBINED WITH DEXAMETHASONE, IN THE PREVENTION OF CISPLATIN-INDUCED EMESIS
Authors: BASURTO C CICCARESE G PALLADINO MA PICCIAFUOCO M RICCI S ANTONUZZO A ALLEGRINI G CONTE PF COGNETTI F CIRULLI S COLELLA E MILELLA M SAVARESE A STANI S CONTU A OLMEO N PIRO S PIRAS M PILO L PILO P NUZZO A URSINI LA TARABORRELLI M MELENA S BASILICO L BUZZI F BRUGIA M TRIPPA F DELRIO S TAGLIAVENTI M PICECE V CASSANDRINI P CIRILLO M MAGAROTTO R RECALDIN E CLERICO M BARTETTO O MORANDINI MP BAINOTTI L BONI C MORETTI G SAVOLDI L TATEO S CHIAPPARINI I ZARA C CATALANO G CASCINU S ALESSANDRONI P MASSIDDA B IONTA MT PEDDITZI E MONTINARI F CASARTELLI C MANDELLI D ROTONDO SG LELLI G CILENTI G MORRITTI M PUSCEDDU G SALARIS G PRESTI ML FAVALLI G GAMBINO A RAVELLI V CORTESI E GIOACCHINI N OLIVA A DAZZI C MONTANARI L CRUCIANI G DEMARINIS F SCARFONE G BOLIS MC SCAGLIOTTI G SELVAGGI G DONATI D MALACARNE P SANTORO A PARRA HS LOCATELLI MC LUPORINI G SANSONI E MATERA G FAVA C
Citation: C. Basurto et al., ONDANSETRON VERSUS GRANISETRON, BOTH COMBINED WITH DEXAMETHASONE, IN THE PREVENTION OF CISPLATIN-INDUCED EMESIS, Annals of oncology, 6(8), 1995, pp. 805-810
RESPONSE TO 2ND-LINE WEEKLY CISPLATIN CHEMOTHERAPY IN OVARIAN-CANCER PREVIOUSLY TREATED WITH A CISPLATIN-BASED OR CARBOPLATIN-BASED REGIMEN
Authors: BOLIS G SCARFONE G LUCHINI L FERRARIS C ZANABONI F PRESTI M GIARDINA G VILLA A PARAZZINI F
Citation: G. Bolis et al., RESPONSE TO 2ND-LINE WEEKLY CISPLATIN CHEMOTHERAPY IN OVARIAN-CANCER PREVIOUSLY TREATED WITH A CISPLATIN-BASED OR CARBOPLATIN-BASED REGIMEN, European journal of cancer, 30A(12), 1994, pp. 1764-1768
ONDANSETRON PLUS DEXAMETHASONE VERSUS METOCLOPRAMIDE PLUS DEXAMETHASONE PLUS DIPHENHYDRAMINE IN CISPLATIN-TREATED PATIENTS WITH OVARIAN-CANCER
Authors: FAVALLI G ROILA F TONATO M DEANGELIS V BALLATORI E DELFAVERO A BASURTO C CORGNA E PALLADINO MA PICCIAFUOCO M CICCARESE G PATOIA L GARBELLI R BIANCHI UA SCARFONE G FERRARIS C BOLIS MC COGNETTI F COLELLA E BUZZI F DELRIO S SABBATINI R SILINGARDI V MATERA G CELLERINO R DAZZI C MARANGOLO M LEONARDI M CANALETTI R BABILONTI L ZARA C DONATI D AMADORI D FERRARI M
Citation: G. Favalli et al., ONDANSETRON PLUS DEXAMETHASONE VERSUS METOCLOPRAMIDE PLUS DEXAMETHASONE PLUS DIPHENHYDRAMINE IN CISPLATIN-TREATED PATIENTS WITH OVARIAN-CANCER, Supportive care in cancer, 2(3), 1994, pp. 167-170
ON THE RELATIONSHIP BETWEEN NAUSEA AND VOMITING IN PATIENTS UNDERGOING CHEMOTHERAPY
Authors: DEANGELIS V BALLATORI E ROILA F TONATO M DELFAVERO A BASURTO C BRACARDA S CORGNA E PICCIAFUOCO M PATOIA L FAVALLI G GARBELLI R BIANCHI UA SCARFONE G FERRARIS C BOLIS MC COGNETTI F COLELLA E BUZZI F DELRIO S SABBATINI R FEDERICO M MATERA G CELLERINO R DAZZI C MARANGOLO M LEONARDI M CANALETTI R BABILONTI L ZARA C DONATI D AMADORI D FERRARI M
Citation: V. Deangelis et al., ON THE RELATIONSHIP BETWEEN NAUSEA AND VOMITING IN PATIENTS UNDERGOING CHEMOTHERAPY, Supportive care in cancer, 2(3), 1994, pp. 171-176
CISPLATIN-INDUCED DELAYED EMESIS - PATTERN AND PROGNOSTIC FACTORS DURING 3 SUBSEQUENT CYCLES
Authors: ROILA F TONATO M DEANGELIS V BALLATORI E OLIVIERI A DELFAVERO A BASURTO C CORGNA E PICCIAFUOCO M PALLADINO MA CICCARESE G FAVALLI G GARBELLI R BIANCHI UA SCARFONE G FERRARIS C BOLIS MC COGNETTI F CERCATO MC BUZZI F TRIPPA F SABBATINI R SILINGARDI V MATERA G GRAMAZIO A DAZZI C MARANGOLO M LEONARDI M CANALETTI R TATEO S ZARA C DONATI D SANSONI E FERRARI M
Citation: F. Roila et al., CISPLATIN-INDUCED DELAYED EMESIS - PATTERN AND PROGNOSTIC FACTORS DURING 3 SUBSEQUENT CYCLES, Annals of oncology, 5(7), 1994, pp. 585-589
DIFFERENCE IN PERSISTENCE OF EFFICACY OF 2 ANTIEMETIC REGIMENS ON ACUTE EMESIS DURING CISPLATIN CHEMOTHERAPY
Authors: ROILA F DELFAVARO A BALLATORI E OLIVIERI A TONATO M DEANGLIS V BASURTO C BRACARDA S CORGNA E PICCIAFUOCO M PATOIA L FAVAUI G GARBELLI R BIANCHI UA SCARFONE G FERRARIS C BOLIS MC COGNETTI F COLELLA E BUZZI F DELRIO S SABBATINI R FEDERICO M MATERA G CELLERINO R DAZZI C MARANGGLO M LEONARDI M CANALETTI R BABILONTI L ZARA C DONATI D AMADORI D FERRARI M
Citation: F. Roila et al., DIFFERENCE IN PERSISTENCE OF EFFICACY OF 2 ANTIEMETIC REGIMENS ON ACUTE EMESIS DURING CISPLATIN CHEMOTHERAPY, Journal of clinical oncology, 11(12), 1993, pp. 2396-2404
CARCINOMA OF THE CERVIX - VALUE OF PLAIN AND GADOLINIUM-ENHANCED MR-IMAGING IN ASSESSING DEGREE OF INVASIVENESS
Authors: SIRONI S DECOBELLI F SCARFONE G COLOMBO E BOLIS G FERRARI A DELMASCHIO A
Citation: S. Sironi et al., CARCINOMA OF THE CERVIX - VALUE OF PLAIN AND GADOLINIUM-ENHANCED MR-IMAGING IN ASSESSING DEGREE OF INVASIVENESS, Radiology, 188(3), 1993, pp. 797-801
Risultati: 1-19 |